Clinical Trial: A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839105) titled 'A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies' on Feb. 18.

Brief Summary: The purpose of this phase I clinical study was to evaluate the safety and tolerability of AWT020 monotherapy and combination with other antitumor therapies in patients with advanced malignancies

Study Start Date: Feb. 14

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor

Intervention: DRUG: Taxol

135~175 mg/m2, Q3W

DRUG: Cisplatin or Carboplatin

Cisplatin(75 mg/m2, Q3W) or Carboplatin (AUC=5~6, Q3W)

DRUG: ...